Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
BACKGROUND
Subclinical demyelinating lesions may occur in the brains of asymptomatic individuals.


OBJECTIVE
To describe the clinical and magnetic resonance imaging (MRI) follow-up of patients with subclinical demyelinating lesions that fulfill the Barkhof/Tintoré criteria.


METHODS
Prospective study.


METHODS
University-affiliated teaching hospitals.


METHODS
Fifty-three women and 17 men with subclinical demyelinating lesions (mean age, 35.63 years).


METHODS
Cerebrospinal fluid, MRI, and visual evoked potential measurements.


METHODS
All patients underwent their first brain MRI for various medical problems that were not suggestive of multiple sclerosis (MS). The patients' physicians proposed that they undergo paraclinical studies (blood, cerebrospinal fluid, and visual evoked potential analysis) and follow-up with MRI.


RESULTS
Twenty-three patients (33%) had clinical conversion: 6 to optic neuritis, 6 to myelitis, 5 to brainstem symptoms, 4 to sensitive symptoms, 1 to cerebellar symptoms, and 1 to cognitive deterioration. The mean time between the first brain MRI and the first clinically isolated syndrome was 2.3 years (range, 0.8-5.0 years). Twelve patients had been treated with immunomodulators after a clinically isolated syndrome. Examination of pejorative markers for clinical conversion showed that sex, number of T2 lesions, presence of oligoclonal bands, and IgG index were not statistically different in patients with MS determined by MRI compared with clinically definite MS. Visual evoked potential abnormalities, young age, and gadolinium enhancement on follow-up MRI were more frequent in clinically definite MS than in MS determined by MRI.


CONCLUSIONS
In this cohort, we determined the rate of clinical conversion (33%) during a mean follow-up of 5.2 years. To our knowledge, this is the first clinically isolated syndrome cohort with preclinical follow-up. Early treatment of these patients with MS determined by MRI should be discussed.
Lebrun
Christine
C
Departments of Neurology, University of Nice Sophia Antipolis, 06002 Nice, France. lebrun.c@chu-nice.fr
Bensa
Caroline
C
Debouverie
Marc
M
Wiertlevski
Sandrine
S
Brassat
David
D
de Seze
Jerome
J
Rumbach
Lucien
L
Pelletier
Jean
J
Labauge
Pierre
P
Brochet
Bruno
B
Tourbah
Ayman
A
Clavelou
Pierre
P
D000293:Adolescent; D000328:Adult; D001921:Brain / Q000473:pathology* / Q000503:physiopathology*; D002097:C-Reactive Protein / Q000378:metabolism; D015331:Cohort Studies; D018450:Disease Progression; D005074:Evoked Potentials, Visual / Q000502:physiology*; D005260:Female; D006801:Humans; D007525:Isoelectric Focusing / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000503:physiopathology; D009460:Neurologic Examination; D010775:Photic Stimulation / Q000379:methods; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D016019:Survival Analysis; D013997:Time Factors; D055815:Young Adult; D005719:gamma-Globulins / Q000378:metabolism
D005719:gamma-Globulins; D002097:C-Reactive Protein